Platelet Rich Plasma Market Research 2019-2024; Regional Industry Segment by Production, Consumption, Revenue and Growth Rate

(The Express Wire via Comtex)

Global Platelet Rich Plasma Industry research report studies latest Platelet Rich Plasma aspects market size, share, trends, industry summary and Platelet Rich Plasma growth during the forecast period (2019-2024). The study report comprehensively determines several aspects which are very significant while observing global market on a minute level which contains analysis over arise of Platelet Rich Plasma industry along with year-on-year manufacturing advancement, business environment and evolution rate over the years.

Global “Platelet Rich Plasma Market” is an overview of the global market is provided with prime focus on factors boosting and hampering market. This will help investors get a clear understanding on which aspects to focus on and how to economically support the market globally. The impact of prevailing regulatory scenario on both regional and worldwide Platelet Rich Plasma market is provided detail in this report.

Market Overview:

  • The global platelet-rich plasma market is expected to register a CAGR of approximately 14% over the forecast period. The key factors that are augmenting the growth of the market include rising incidences of sports injuries, increasing number of androgenic alopecia patients, growing use of platelet-rich plasma in various therapeutic areas, and rise in the prevalence of arthritis.
  • Osteoarthritis (OA) is the most common form of chronic disorder of the joints, and it has some detrimental effects on the quality of life of the patients. Progressive cartilage destruction, osteophyte formation, and subchondral sclerosis are characteristic to osteoarthritis. Platelet-rich plasma (PRP) is an autologous concentration of a high number of platelets in a small volume of plasma. PRP is prepared to centrifuge blood. In knee OA, PRP injections target to promote cartilage repair in order to relieve symptoms of osteoarthritis, hence delaying the need for joint replacement surgery.
  • The rising prevalence of the arthritis is augmenting the demand of the blood products, which is ultimately helping the growth of the platelet-rich plasma market.

Get a Sample Copy of the Report -

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

  • Bio Product Laboratory Ltd (BPL)
  • Biolife Plasma Services
  • Biotest AG
  • Cambryn Biologics LLC
  • China Biologic Products Inc.
  • CSL Ltd
  • Grifols International SA
  • Kedrion SpA
  • LFB SA
  • Octapharma AG

Scope of the Report:

  • As per the , platelet-rich plasma (PRP) prolotherapy, like dextrose prolotherapy, is a method of injection designed to stimulate healing. Platelet-rich plasma is defined as autologous blood with concentrations of platelets above baseline levels, which contains at least seven growth factors.

Market Dynamics:

  • Drivers: (Developing regions and growing markets)
  • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
  • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

The report provides key statistics on the market status of the Platelet Rich Plasma Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Platelet Rich Plasma.

For More Information or Query or Customization Before Buying, Visit at -

Key questions answered in the report include:

  • What will the market size and the growth rate be in 2024?
  • What are the key factors driving the global Platelet Rich Plasma market?
  • What are the key market trends impacting the growth of the global Platelet Rich Plasma market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global Platelet Rich Plasma market?
  • What are the market opportunities and threats faced by the vendors in the global Platelet Rich Plasma market?
  • Trending factors influencing the market shares of the relevant regions.
  • What are the key outcomes of the five forces analysis of the global Platelet Rich Plasma market?

Key Market Trends:

Pure PRP Segment by Type is Expected to Hold the Largest Market Share

The pure PRP segment of the global platelet rich plasma market is believed to have the largest market share.

The prime factor responsible for the growth of this segment is the significance of this type of platelet plasma for the person. Pure PRP has an edge over traditional PRP, as it requires a two-step concentration process that helps in eliminating unwanted red blood cells (RBCs) and neutrophils. RBCs (that have no therapeutic effects for regeneration) can create a more viscous solution that can be more painful when injected. Neutrophils, a type of white blood cell, have inflammatory components that may increase pain and inflammation post-treatment.

Pure PRP helps the stem cells and regenerative cells in the repair and in rebuilding the damaged tissue. This ultimately speeds up the healing process and reduces pain. In addition, it promotes increased strength and improves the overall function. Therefore, owing to the contribution of pure PRP in the healing process and the rising use of it as a blood product, the segment is expected to dominate the market in the coming future.

North America Dominates the Market and is Expected to Continue the Same Trend for Next Few Years

North America currently dominates the platelet-rich plasma market and is expected to continue its stronghold for a few more years. The United States is a major market, and this is mainly due to the US government's initiatives to develop blood products. In addition, the emergence and adoption of novel technologies are going to help the market in a positive manner.

Purchase this Report (Price 4250 USD for single user license) -

Study objectives of Platelet Rich Plasma Market Report:

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Platelet Rich Plasma market
  • To provide insights into factors influencing and affecting market growth
  • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
  • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
  • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors, technology trends, and market trends that influence the global Platelet Rich Plasma market

Detailed TOC of Platelet Rich Plasma Market Report 2019-2024:

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Sports Injuries
4.2.2 Increasing Number of Androgenic Alopecia Patients
4.2.3 Growing Use of Platelet-rich Plasma in Various Therapeutic Areas
4.2.4 Rising Prevalence of Arthritis
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 High Prices of Plasma Therapy
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Pure PRP
5.1.2 Leukocyte-rich PRP
5.1.3 Pure Platelet-rich Fibrin
5.1.4 Leukocyte-rich Fibrin
5.2 By Source
5.2.1 Autologous
5.2.2 Allogenic
5.3 By Application
5.3.1 Orthopedic Arthritis Chronic Tendinitis Bone Repair and Regeneration
5.3.2 Dermatology Androgenic Alopecia Plastic Surgery Cardiac Muscle Injury Dental Nerve Injury Other Applications
5.3.3 By End User Hospitals and Clinics Research Institutes Other End Users
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Bio Product Laboratory Ltd (BPL)
6.1.2 Biolife Plasma Services
6.1.3 Biotest AG
6.1.4 Cambryn Biologics LLC
6.1.5 China Biologic Products Inc.
6.1.6 CSL Ltd
6.1.7 Grifols International SA
6.1.8 Kedrion SpA
6.1.9 LFB SA
6.1.10 Octapharma AG


Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [email protected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Platelet Rich Plasma Market Research 2019-2024; Regional Industry Segment by Production, Consumption, Revenue and Growth Rate